OXERVATE (cenegermin-bkbj)

OXERVATE (cenegermin-bkbj) 

SELF ADMINISTRATION

Indications for Prior Authorization:

• Treatment of neurotrophic keratitis

Patients must meet the following criteria for the indication(s) above:

• Diagnosis of neurotrophic keratitis confirmed by chart note documentation, AND
• Prescribed by or in consultation with an ophthalmologist

Dosing:

• One drop into the affected eye(s) 6 times per day at 2-hour intervals for 8 weeks

Approval:

• 8 weeks